Mohamed Shehab Eldin, MD
Vascular Neurology · Altoona, PANPI 1376920736
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,898 of the $4,293 with a category attached, or 67.5%. 9 manufacturers reported payments, led by Microvention, Inc. at 45.2% of the total. 2025 is the largest year on record at $2,189, more than ten times the $62 reported in 2019.
Across 33 payments — averaging $130.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microvention, Inc.$2K
- Penumbra, Inc.$2K
- Johnson & Johnson$374
- Imperative Care, Inc$295
- EMD Serono, Inc.$62
- Stryker$43
- plus $60 from 3 others
What the payments were for
- Travel & lodging$2,89868%
- Food & beverage$1,33931%
- Education$561%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microvention, Inc. | 6 | $1,939 |
| Penumbra, Inc. | 7 | $1,521 |
| Johnson & Johnson | 10 | $374 |
| Imperative Care, Inc | 4 | $295 |
| EMD Serono, Inc. | 2 | $62 |
| Stryker | 1 | $43 |
| AbbVie | 1 | $28 |
| CSL Behring | 1 | $20 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WEB Aneurysm Embolization System$1,752
- Penumbra System$1,467
- TRUFILL$148
- Embotrap$122
- Cerenovus Enterprise$122
How this compares
$4,293 in reported general payments places this provider in the 85th percentile of 52 vascular neurology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 14 | $227 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Altoona
- Mausaminben HathidaraAltoona$409
- Raul NogueiraPittsburgh$928K
- Scott KasnerPhiladelphia$210K
- Jussie Correia LimaPittsburgh$85K
- Alhamza Al-BayatiPittsburgh$66K
- Michael McGarveyPhiladelphia$15K
- Steven MessePhiladelphia$14K
- Neil SuryadevaraPittsburgh$9K
- Donna GeorgePhiladelphia$4K
- Kerstin BettermannMechanicsburg$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.